SAM-001

N/A

Report date: 2023/09/28 17:00:15
NME

Base Information

Drug NameSAM-001
Drug Alias NameSAM-001
ClassificationSmall molecules
Mechanisms of ActionTransient receptor potential channel mucolipin 1 activators
TargetsTransient receptor potential channel mucolipin 1
Therapy Area/IndicationsMotor Neuron DiseaseAmyotrophic Lateral SclerosisParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSamsara Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSamsara Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMotor Neuron DiseaseAmyotrophic Lateral SclerosisParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A